Krispy Kreme falls as Q2 loss widens amid McDonald's partnership exit

Krispy Kreme (DNUT) shares fell approximately 5% after reporting a wider-than-expected Q2 adjusted loss of $0.15 per share, significantly missing analyst estimates, and a 13.5% year-over-year revenue decline. This underperformance was primarily due to the terminated McDonald's USA partnership, which resulted in $406.9 million in non-cash impairment charges and a 63.3% plummet in adjusted EBITDA. Consequently, the company has halted its quarterly dividend, sold its Insomnia Cookies stake for $75 million, and launched a comprehensive turnaround plan focused on refranchising international markets and enhancing operational efficiency.

Analysis

Krispy Kreme's second-quarter results reveal a significant operational and financial setback, primarily driven by the termination of its partnership with McDonald's USA. The company reported an adjusted loss per share of $0.15, starkly missing analyst expectations of a $0.04 loss, which triggered a 5% decline in its share price. While revenue of $379.8 million narrowly beat consensus, it represented a 13.5% year-over-year decline and a 0.8% drop in organic revenue, signaling underlying weakness. The financial impact of the partnership's dissolution was severe, leading to $406.9 million in non-cash goodwill and asset impairment charges and a GAAP net loss of $441.1 million. This strategic failure crushed profitability, with adjusted EBITDA plummeting 63.3% to $20.1 million and margins contracting sharply to 5.3% from 12.5% in the prior year. In response, management has initiated a comprehensive turnaround plan, taking decisive actions to preserve capital by halting its dividend and selling its Insomnia Cookies stake for $75 million to reduce debt. The company is now focused on removing costs associated with the failed partnership and executing a restructuring that includes refranchising major international markets to improve returns and operational efficiency.

Key Decisions for Investors

• Investors should treat this as a turnaround situation, focusing on management's ability to execute on its cost-cutting promises and replace lost distribution with profitable new channels.
• The suspension of the dividend and the sale of non-core assets are necessary but defensive moves; progress on the international refranchising plan will be a key catalyst for restoring balance sheet health and investor confidence.
• It is critical to monitor for a recovery in adjusted EBITDA margins from the current low of 5.3% and stabilization in organic revenue in subsequent quarters as the primary indicators of whether the new strategy is gaining traction.